File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Demand for male contraception

TitleDemand for male contraception
Authors
Keywordscontraceptive development
contraceptive responsibility
male fertility
male hormonal contraception
male non-hormonal contraception
male reproductive rights
market analysis
Issue Date2012
Citation
Expert Review of Pharmacoeconomics and Outcomes Research, 2012, v. 12, n. 5, p. 605-613 How to Cite?
AbstractThe biological basis for male contraception was established decades ago, but despite promising breakthroughs and the financial burden men increasingly bear due to better enforcement of child support policies, no viable alternative to the condom has been brought to market. Men who wish to control their fertility must rely on female compliance with contraceptives, barrier methods, vasectomy or abstinence. Over the last 10 years, the pharmaceutical industry has abandoned most of its investment in the field, leaving only nonprofit organisations and public entities pursuing male contraception. Leading explanations are uncertain forecasts of market demand pitted against the need for critical investments to demonstrate the safety of existing candidate products. This paper explores the developments and challenges in male contraception research. We produce preliminary estimates of potential market size for a safe and effective male contraceptive based on available data to estimate the potential market for a novel male method. © 2012, Expert Reviews Ltd. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/326932
ISSN
2023 Impact Factor: 1.8
2023 SCImago Journal Rankings: 0.671
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorDorman, Emily-
dc.contributor.authorBishai, David-
dc.date.accessioned2023-03-31T05:27:35Z-
dc.date.available2023-03-31T05:27:35Z-
dc.date.issued2012-
dc.identifier.citationExpert Review of Pharmacoeconomics and Outcomes Research, 2012, v. 12, n. 5, p. 605-613-
dc.identifier.issn1473-7167-
dc.identifier.urihttp://hdl.handle.net/10722/326932-
dc.description.abstractThe biological basis for male contraception was established decades ago, but despite promising breakthroughs and the financial burden men increasingly bear due to better enforcement of child support policies, no viable alternative to the condom has been brought to market. Men who wish to control their fertility must rely on female compliance with contraceptives, barrier methods, vasectomy or abstinence. Over the last 10 years, the pharmaceutical industry has abandoned most of its investment in the field, leaving only nonprofit organisations and public entities pursuing male contraception. Leading explanations are uncertain forecasts of market demand pitted against the need for critical investments to demonstrate the safety of existing candidate products. This paper explores the developments and challenges in male contraception research. We produce preliminary estimates of potential market size for a safe and effective male contraceptive based on available data to estimate the potential market for a novel male method. © 2012, Expert Reviews Ltd. All rights reserved.-
dc.languageeng-
dc.relation.ispartofExpert Review of Pharmacoeconomics and Outcomes Research-
dc.subjectcontraceptive development-
dc.subjectcontraceptive responsibility-
dc.subjectmale fertility-
dc.subjectmale hormonal contraception-
dc.subjectmale non-hormonal contraception-
dc.subjectmale reproductive rights-
dc.subjectmarket analysis-
dc.titleDemand for male contraception-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1586/erp.12.52-
dc.identifier.pmid23186401-
dc.identifier.scopuseid_2-s2.0-84877112269-
dc.identifier.volume12-
dc.identifier.issue5-
dc.identifier.spage605-
dc.identifier.epage613-
dc.identifier.eissn1744-8379-
dc.identifier.isiWOS:000313299000014-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats